Autophosphorylation at serine 166 regulates RIP kinase 1-mediated cell death and inflammation

Lucie Laurien1, Masahiro Nagata1, Hannah Schünke1

  • 1Institute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Nature Communications
|April 10, 2020
PubMed

Insights

Receptor interacting protein kinase 1 (RIPK1) autophosphorylation at serine 166 is crucial for RIPK1 kinase-dependent apoptosis, necroptosis, and inflammatory diseases. This S166 phosphorylation acts as a biomarker for RIPK1-driven pathologies.

Area of Science:

  • Molecular biology
  • Cellular signaling
  • Immunology

Background:

  • Receptor interacting protein kinase 1 (RIPK1) is a key regulator of cell death and inflammation.
  • RIPK1 kinase activity is implicated in inflammatory and degenerative diseases.
  • Mechanisms of RIPK1-dependent cell death signaling are not fully understood.

Purpose of the Study:

  • To investigate the role of RIPK1 autophosphorylation in regulating RIPK1 kinase activity.
  • To determine the impact of RIPK1 phosphorylation on apoptosis and necroptosis.
  • To assess the in vivo relevance of RIPK1 phosphorylation in inflammatory pathologies.

Main Methods:

  • Site-directed mutagenesis to study RIPK1 phosphorylation at serine 166 (S166).
  • In vitro kinase assays to measure RIPK1 activity.
  • In vivo mouse models of inflammatory diseases.

Main Results:

  • RIPK1 autophosphorylation at S166 is critical for RIPK1 kinase-dependent apoptosis and necroptosis.
  • S166 phosphorylation is required for RIPK1 kinase-dependent pathogenesis in vivo.
  • S166 phosphorylation modulates RIPK1 kinase activation but is insufficient to induce cell death alone.

Conclusions:

  • S166 autophosphorylation licenses RIPK1 kinase activity to induce cell death and inflammation.
  • RIPK1 S166 phosphorylation is a critical event in RIPK1-dependent pathologies.
  • S166 phosphorylation serves as a potential biomarker for RIPK1 kinase-dependent diseases.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K